CompletedNot Applicable

Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age

Mexico529 participantsStarted 2017-11-09

Plain-language summary

This study evaluates the effect of zinc over the duration, severity and relapse of acute diarrheic disease, in children between 6 and 59 months of age. One study group will receive a tablet that contains 20 mg of zinc, and the other study group will receive a tablet,that does not contain zinc, it is a tablet that investigators will use as control.

Who can participate

Age range6 Months – 59 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Both sexes * Children attended in the sentinel centers * Clinical diagnosis of acute diarrhea disease * Parents have not planned moving to other location in a time period of at least one year. Exclusion Criteria: * Deficient intestinal absorption syndrome * Acrodermatitis enterohepatic * Zinc sulfate hypersensitivity * Leucine metabolic disorders * Secondary lactose intolerance * Galactosemia lactase primary deficiency * Allergy to cow milk protein * Children that are supplemented with zinc for the last 6 months

What they're measuring

Diarrhea duration

Timeframe: 10 days

Stool frequency

Timeframe: 10 days

Trial details

NCT IDNCT04061538

SponsorInstituto Nacional de Salud Publica, Mexico

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-09-14

View on ClinicalTrials.gov More Diarrhoea;Acute trials